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Purpose: Advanced glycation endproduct (AGE) formation on the basement membrane of retinal capillaries has been
previously described but the impact of these adducts on capillary endothelial cell function vascular repair remains
uncertain. This investigation has evaluated retinal microvascular endothelial cells (RMECs) growing on AGE-modified
fibronectin (FN) and determined how this has an impact on cell-substrate interactions and downstream oxidative responses
and cell survival.
Results: AGE-FN reduced RMEC attachment and spreading when compared to FN controls (p<0.001). RGDS peptide
enhanced cell attachment on AGE-FN (p<0.001), while the scrambled peptide had no effect. FAK phosphorylation in
AGE-exposed RMECs was reduced in a time-dependent fashion, while α5β1 integrin-immunoreactivity became focal at
the basal membrane. AGE-exposure induced apoptosis, a response significantly prevented by RGDS peptide. AGE-
exposure caused a significant increase in basal O2- and NADPH-stimulated production by RMECs (p<0.01), while AGE-
FN also increased basement membrane associated mRNA expression (p<0.05).
Conclusions: AGE substrate modifications impair the function of retinal capillary endothelium and their reparative
potential in response to diabetes-related insults. Arginine-specific modifications alter vital endothelial cell interactions
with the substrate. This phenomenon could play an important role in dysfunction and nonperfusion of retinal capillaries
during diabetes.
Progressive  dysfunction  and  depletion  of  the  retinal
microvascular endothelium eventually leads to the capillary
nonperfusion that characterizes the vasodegenerative stages
of diabetic retinopathy. The resultant capillary nonperfusion
and ischemia is linked to sight-threatening neovascularization
and macular edema in many patients. Diabetic retinopathy is
a complex disorder. A wide range of pathogenic pathways
have been proposed that underlie microvascular dysfunction
and  depletion  in  the  diabetic  retina.  Among  these  is  the
irreversible  formation  of  advanced  glycation  endproducts
(AGEs) formed from an array of precursor molecules [1]. α-
Oxaloaldehydes such as glyoxal, methylglyoxal (MGO), and
3-deoxyglucosone occur at high levels in diabetic plasma, or
are significantly elevated in cells exposed to high glucose
[1]. They can react directly with protein to yield intracellular
and extracellular AGEs [2]. For example, MGO can give rise
to the adducts Nε-(carboxyethyl)lysine (CEL) and arginine-
hydroimidazolone, which have been shown to have significant
pathogenic effects in cells and tissues [2,3].
In  anchorage-dependent  cells,  such  as  the  vascular
endothelium, functionality and continued survival depends on
appropriate  interactions  with  basement  membrane  (BM)
component  proteins  [4].  Detachment  from  this  substrate
ultimately results in an apoptotic death response known as
anoikis [5]. Under normal conditions cellular attachment to
the extracellular matrix is mediated by integrins, which serve
as a direct physical link between the subcellular matrix and
the  intracellular  actin  cytoskeleton,  through  multiprotein
complexes, known as focal adhesions [4]. Focal adhesion
formation initiates subcellular localization of the signaling
enzyme focal adhesion kinase (FAK) to sites of cell adhesion
[4].  While  growth  factor  and  neuropeptide  stimulus  can
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Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif
modulates retinal microvascular endothelial cell dysfunction
Methods: RMECs were grown on methylglyoxal-modified FN (AGE-FN) or native FN as a control. RMEC attachment
and spreading was quantified. In a separate treatment, the AGE-FN substrate had Arg-Gly-Asp-Ser (RGDS) or scrambled
peptide added before seeding. Phosphorylation of focal adhesion kinase (FAK) and α5β1 integrin localization was assessed
and apoptosis evaluated. In a subset of RMECs that remained attached to the AGE-FN substrate, the production of
superoxide (O2-) was assayed using dihydroethidium (DHE) fluorescence or lucigenin, in the presence or absence of
NADPH. The specificity of the O2- assays was confirmed by inhibition in the presence of polyethylene-glycol-superoxide
dismutase (PEG-SOD). AGE-mediated changes to mRNAs encoding key basement membrane proteins and regulatory
enzymes were investigated using real-time RT–PCR.
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a.stitt@qub.ac.ukinduce FAK tyrosine397 autophosphorylation and activation of
the Phosphoinositide 3-kinase (PI3-kinase), a major mode of
FAK regulation is via integrin-dependent adhesion to the BM
component proteins: fibronectin (FN) and collagen IV [6].
This  pathway  promotes  cell  survival  via  downstream
phosphorylation and subsequent inactivation of several pro-
apoptotic  effectors,  including  caspase-9  [7]  and  the  pro-
apoptotic Bcl-2 homolog, BAD [8].
The proteins comprising the vascular BM are among the
longest lived in the body and, as such, are highly susceptible
to  hyperglycemia-induced  AGE  modification  [9].  Indeed,
thickening of retinal capillary BMs is a hallmark lesion of
diabetic retinopathy in diabetic animal models and patients
with diabetes [10]. This pathology has been widely used as a
postmortem measure of disease severity [11,12]. Diabetes
also leads to a net decrease in BM proteoglycan content, which
alters  charge  selectivity  and  permeability  across  capillary
walls  [13].  It  has  been  suggested  that  BM  modifications
contribute to impaired endothelial or pericyte communication,
capillary contractility, or cell interactions with constituent BM
proteins [14-16].
AGEs accumulate in the retinal capillary BMs of diabetic
rats  [11].  These  adducts  on  BM  constituent  proteins  may
influence  normal  endothelial  cell  function  [16-18]  and
vascular reparative processes [19]. AGE adducts on BM also
lead to impaired cell-matrix interactions and growth factor
depletion  in  endothelial  cells  [20],  bone  marrow-derived
endothelial progenitor cells (EPCs) [19], and pericytes [16,
21]. This has a marked impact on pro-survival signaling in
microvascular endothelial cells and ultimately leads to cell
death  by  anoikis,  possibly  through  specific,  MGO-linked
arginine  modifications  in  ARG-GLY-ASP  (RGD)  and
glycine-phenylalanine-hydroxyproline-glycine-glutamate-
arginine  (GFOGER)  integrin  binding  sites  [17].  Impaired
integrin-mediated BM interactions and AGE-exposure via the
basal  plasma  membrane  has  serious  implications  for
endothelial cell function in the context of diabetic retinopathy.
“Endotheliopathy” in this complication, as manifest by cell
dysfunction  and  oxidative  stress,  breakdown  of  the  blood
retinal barrier, and progressive loss of capillary endothelium
could be, at least in part, linked to AGE modification of the
vascular BM.
METHODS
Preparation of AGE-modified fibronectin: Unless otherwise
stated, all reagents were purchased from the Sigma Chemical
Retinal  microvascular  endothelial  cells  attachment  and
spreading: Retinal microvascular endothelial cells (RMECs)
were isolated from bovine retina by established protocols
[23].  Briefly,  bovine  eyes  were  transported  from  a  local
abbatoir on ice and the retinas removed and washed free of
RPE  in  Dulbecco's  minimal  essential  medium  (MEM;
Invitrogen Life Technologies, Paisley, UK). The neural retina
was then homogenized in MEM and filtered through an 87 µm
filter. The trapped microvessels were digested at 37 °C for
approximately  20–30  min  in  PBS  containing  200  µg/ml
pronase, 200 µg/ml DNAase, and 50 µg/ml collagenase. The
filtrate was microscopically examined to determine the end
point  for  maximum  retrival  of  endothelial  cells.  Vessel
fragments were then trapped in a 53 µm filter and resuspended
in Dulbecco’s modified Eagles medium (DMEM) containing
antibiotics  (0.2  mg  streptomycin  sulfate,  0.12  mg  benzyl
penicillin and 0.2 mg kanamycin), fungizone (2.5 µg/ml) and
15% fetal calf serum (FCS; Invitrogen Life Technologies).
This  mixture  was  seeded  into  25  cm2  Falcon  flasks  and
maintained  at  37  °C  in  a  mixture  of  5%  CO2  and  air.
Endothelial cell growth was supported by DMEM containing
7.5% human platelet-poor plasma-derived serum, 5 µg/ml
insulin  and  antibiotics.  All  subsequent  experiments  were
performed on confluent monolayers of cells derived from
passages 1 to 4 and plated out onto multiwell dishes. RMEC
attachment  was  visualized  in  vitro  by  phase-contrast
microscopy and quantified using manual cell counts. RMECs
at a cell density of 0.9×104 were seeded onto 3 cm2 Petri dishes
(Nunc Plasticware, Rochester, NY) that had been coated with
FN or AGE-FN. After 3 or 6 h, the cells were washed twice
with fresh PBS to dislodge nonadherent cells after which the
adherent cells were fixed in 4% paraformaldehyde (PFA) for
1 h at room temperature. Fixation was followed by washing
in PBS. The number of adherent cells was counted in six
separate fields of view with the aid of an eyepiece graticule.
For assessment of RMEC spreading, 0.9×104 cells were
allowed to attach and spread on FN or AGE-FN for 6 h at
37  °C.  Following  incubation,  cells  were  visualized  and
designated as either “spread” or “not spread.” Spread cells
were defined as those that achieved normal cell morphology
similar to that found in sparse culture, while not spread cells
were morphologically typified by a rounded up, phase-bright
appearance. The numbers of spread and not spread cells were
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In  the  current  investigation  we  hypothesize  that
progressive  modification  of  fibronectin  by  advanced
glycation could contribute to diabetes-related retinal capillary
endotheliopathy.  Using  in  vitro  approaches,  we  assess
endothelial cell dynamics on a diabetic-like substrate. The
data offers fresh insight into the impact of AGE-modification
and in particular the relative importance of RGD recognition
in retinal capillary dysfunction during progressive diabetes.
Co. Ltd., (Poole, Dorset, UK). AGE-modified FN (AGE-FN)
was prepared as previously described [19,22]. Briefly, four-
well chamber slides were coated with FN at 2 μg/cm2 and
incubated with MGO at 10, 50, or 100  μM or with PBS
(137 mM NaCl, 2.7 mM KCl, 100 mM Na2HPO4, 2 mM
KH2PO4) alone for one week at 37 °C. Following incubation,
slides were extensively washed with PBS to remove MGO and
unbound  adducts.  The  levels  of  the  MGO-derived  AGE
adducts argpyrimidine and CEL were assayed by HPLC and
competitive AGE-ELISA, respectively, and we have already
reported this [19].counted in six separate fields of view and the percentage of
spread cells determined.
To  assess  the  impact  of  adding  “exogenous”  RGD
peptide, we added the Arg-Gly-Asp-Ser (RGDS) peptide and
a  scrambled  control  peptide  (Ser-Asp-Gly-Arg-Gly
(SDGRG)) to substrates. SDGRG does not stimulate integrins
and is often used as an appropriate control peptide for RGD
[24].  The  peptides  were  added  to  the  FN  or  AGE-FN
substrates on 3 cm2 Petri dishes at concentrations of 1, 3, or
6 mM. The peptide was allowed to dry onto the substrate after
which the cells were added as we have described.
Integrin signaling: Cells were exposed to FN or AGE-FN as
outlined. Following the treatment period, attached cells were
then  lysed  on  the  culture  dishes  using  lysis  buffer  that
consisted of double distilled water containing 10 mM Tris Ph
7.2, 158 mM NaCl, 1 mM Na3VO4, 1 mM EDTA, 0.1% SDS,
1%  sodium  deoxycholate,  1%  Triton  X-100,  as  well  as
protease inhibitors (1X CompleteTM mini protease inhibitor
cocktail;  Boehringer  Mannheim,  Mannheim,  Germany).
Protein was extracted on ice and quantification of total protein
(µg/µl) determined using a bicinchoninic acid (BCA) protein
assay (Pierce, Rockford, IL).
An aliquot of each extracted protein sample was diluted
in Laemmli buffer (containing 4% SDS; 20% glycerol; 10%
2-mercaptoethanol; 0.004% bromphenol blue in 0.125 M Tris
HCl).  Protein  from  each  sample  and  10  µl  ProSieve®
molecular  weight  marker  (Cambrex  Bioscience  Inc.,
Rockland, ME) were loaded on a denaturing 4%–20% Tris-
HEPES-SDS gel (Pierce) and separated by molecular weight
using  sodium  dodecyl  sulfate  PAGE  (SDS–PAGE).
Following  SDS–PAGE,  proteins  were  transferred  onto  a
nitrocellulose  membrane  (Pall  Life  Sciences,  Portsmouth,
UK). After transfer, all washes were performed with PBS
containing 0.1% Tween-20. The blocking buffer and antibody
diluents contained 0.1% Tween-20 and 5% Blotto™ non-fat
dry milk (Santa Cruz Biotechnology, Santa Cruz, CA). After
blocking, the membrane was incubated overnight in 1:500
dilution of polyclonal primary antibody (anti-phospho-FAK
(tyrosine397; Upstate Biotechnology). After washing at room
temperature for 4×10 min, the membrane was incubated for 1
h in 1:1,000 dilution of horseradish peroxidase (HRP) labeled
secondary antibody (Santa Cruz Biotechnology). HRP was
detected  with  SuperSignal®  West  Pico  Chemiluminescent
Substrate  (Pierce)  using  a  UVP®  AutoChemi  gel  analysis
system equipped with Labworks™ 4.0 image acquisition and
analysis  software  (UVP.  Inc.,  Upland,  CA).  To  calculate
relative expression, we reprobed membranes with a primary
monoclonal  antibody  to  β-actin.  Densitometry  software
(Labworks™ 4.0, UVP. Inc., Upland) was used to calculate
expression of each protein sample relative to the density of
β-actin.
Confocal  microscopy  for  visualization  of  integrin  α5β1:
α5β1  integrin  was  detected  using  an  immunofluorescence
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protocol. RMECs growing on FN or AGE-FN within four-
well chamber slides were fixed in 4% PFA and subsequently
permeabilized with a PBS solution containing 0.1% Triton X.
To reduce nonspecific binding, we incubated cells with 5%
normal goat serum (NGS) overnight at 4 °C. The RMECs were
then incubated with a monoclonal anti-integrin α5β1 antibody
(clone HA5; Chemicon, Chandlers Ford, Hampshire, UK).
This  antibody  has  been  previously  used  to  localize  this
integrin combination in several cell types [25]. The antibody
was diluted in PBS containing 5% NGS overnight at 4 °C after
which they were washed with PBS and blocked for a further
hour before incubation with a 1:1,000 dilution of Alexa-488
fluorophore  labeled  secondary  antibody  (anti-mouse
Alexa-488; Invitrogen Life Technologies). After extensive
washing,  the  cells  were  then  incubated  with  5  µg/ml
propidium iodide (PI) for 20 min at room temperature to stain
cell nuclei. Cells were washed extensively in PBS, mounted
in Vectashield (Vector Laboratories, Peterborough, UK) and
examined with a Bio-Rad Microradiance confocal scanning
laser microscope (CSLM) equipped with a 25 mV Argon and
1 mV green helium-neon laser. Negative controls, in which
primary  antibody  was  omitted,  ensured  that  the  staining
achieved was specific for α5β1 integrin.
RMEC mitochondrial permeability and caspase-3 activity:
Mitochondrial  changes  were  evaluated  in  pre-apoptotic
RMECs growing on FN or differentially modified AGE-FN
(using 10, 50, and 100 uM MGO). This change was evaluated
using the cationic fluorescent probe 5,5′,6,6’-tetrachloro-1,1’,
3,3′-tetraethylbenzimidazolylcarbocyanie  (JC-1)  that
assesses  voltage  changes  in  membrane  potential  and  thus
mitochondrial membrane permeability. Healthy mitochondria
have the ability to concentrate the green monomeric JC-1
species (emission peak 530 nm) to yield red fluorescent J
aggregates  (emission  peak  590  nm).  Dysfunctional
mitochondria,  however,  are  unable  to  concentrate  the
monomer,  and  there  is  a  net  decrease  in  the  red:green
fluorescence  intensity  ratio.  Changes  in  the  membrane
transmembrane potential RMECs using JC-1 was quantified
using flow cytometry as previously described [16]. Briefly,
RMECs used for these studies were cultured for 3 h on FN-
coated 75 cm2 flasks that had been modified using 10, 50, and
100 uM MGO. Following the treatment period, JC-1 dye at a
final concentration of 5 ug/ml was added to the DMEM for 30
min at 37 °C in the dark. Adherent cells were then detached
via brief exposure to trypsin and versene, pelleted by light
centrifugation,  and  resuspended  in  PBS  at  a  population
density of 1×106/ml. Once the cells were in suspension, the
JC-1 cells were immediately sorted, to exclude cell debris or
doublets,  using  a  FACSCaliber  flow  cytometer  (Becton
Dickinson, Oxford, UK) equipped with a 488 nm argon laser.
Each sample was examined and gated in a forward scatter
versus  a  side  scatter  dot  plot.  The  population  of  RMECs
showing  mitochondrial  permeability  was  determined  by
dividing  the  mean  fluorescence  value  obtained  from  redfluorescence channel by the mean fluorescence value obtained
from the green fluorescence channel. This allowed calculation
of the red:green fluorescence intensity ratio.
As a complementary apoptosis assay, caspase-3 activity
was  examined  using  an  Enzcheck®  Caspase-3  Assay  kit
(Molecular  Probes,  Invotrogen  Life  Technologies)  in
accordance  with  the  manufacturer’s  instructions.  RMECs
were cultured for 3 h on FN- or AGE-FN-coated 75 cm2 flasks
(with or without RGD peptide coating) after which the cells
were washed in PBS. Adherent cells were then detached via
brief  exposure  to  trypsin  and  versene,  pelleted,  and
subsequently re-suspended in PBS at a density of 1×106/ml.
Next, 50 µl of 1X cell lysis buffer was added to each sample
for 30 min, and the samples were centrifuged at 2.5 xg to pellet
cellular debris. Afterwards, 40 µl of the supernatant from each
sample was transferred into individual wells of a 96 well plate
(Nunc), and 50 µl of the 1X cell lysis buffer was used as a
negative control to determine substrate fluorescence. Next,
40 µl of 2X substrate working solution was added to each
sample followed by incubation at room temperature for 30
min. The fluorescence of each sample (excitation=342 nm;
emission=441  nm)  was  measured  on  a  spectrofluorimeter
(Tecan Safire, Tecan, Männedorf, Switzerland).
Superoxide assay: Released superoxide (O2
-) was measured
from RMECs growing on native FN or AGE-FN with an
enhanced chemiluminescence detection using lucigenin as a
substrate [26]. RMECs growing on FN or AGE-FN were
trypsinized. Next, 0.4×104 cells from each group were added
to polycarbonate luminometer tubes that contained Tyrodes-
HEPES  buffer.  The  buffer  comprised  the  following:  140
mmol/l NaCl, 6.0 mmol/l HEPES, 2.0 mmol/l Na2HPO4, 2.0
mmol/l MgSO4, and 5.6 mmol/l dextrose (pH 7.40). Ten µl
lucigenin was added and each sample dark adapted at room
temperature for 10 min after which they were transferred to
the tube housing of a Sirius luminometer (Berthold Detection
Systems, Bleichstr, Germany). Luminescence was recorded
in  both  control  and  AGE-FN-exposed  cells  in  the  both
presence and absence of β-nicotinamide adenine dinucleotide
3′-phosphate (NADPH) and polyethylene-glycol-superoxide
dismutase (PEG-SOD). Peak emission of luminescence was
used to construct bar charts.
Quantitative RT–PCR: RMECs propagated on FN or AGE-
FN were harvested and subjected to total RNA extraction
using the RNeasy mini kit (Qiagen, West Sussex, UK) as per
the manufacturer’s instructions. The amount of RNA was
quantified using a Nano drop, ND-1000 spectrophotometer
(NanodropTechnologies,  Wilmington,  DE)  by  measuring
TABLE 1. PRIMER PAIR SEQUENCES FOR REAL-TIME RT–PCR.
Gene name (abbreviation, accession number) Primer Sequence (5′-3′)
18S F: CTTAGAGGGACAAGTCGCG
R: GGACATCTAAGGGCATCACA
28S F: TTGAAAATCCGGGGGAGAG
R: ACATTGTTCCAACATGCCAG
Matrix Metalloproteinase 1 (mmp1 - AF134714) F: ACTTGTACCGGGTGGCAGCG
R: TGGGATTTTGGGAAGGTCCG
Matrix Metalloproteinase 2 (mmp2 - NM_174745) F: ACTTCTTCCCCCGAAAGCCC
R: GGCACGAGCGAAGGCATCAT
Matrix Metalloproteinase 14 (mmp14 - NM_174390) F: TTCCATGGTGACAGCACGCC
R: ATGGCCCAGCTCGTGCACAG
Tissue Inhibitor Metalloproteinase 1 (timp1 - NM_174471) sense 5′-TCCACAGGTCCCAGAACCGC-3′
antisense 5′-CATGCTGTTCCAGGGAGCCA-3′
Tissue Inhibitor Metalloproteinase 2 (timp2 - NM_174472) sense 5′-ACTCGATGCCCCATGATCCC-3′
antisense 5′-GCAGGAGCCGTCGCTTCTCT-3′
Collagen IV (coll IV M63139) sense 5′-GGTTGATGGGAGAGCCTGGC-3′
antisense 5′-ATCACCTCTGGCCCCTGGCT-3′
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In a parallel assay, dihydroethidium (DHE) was used to
assess O2
- in AGE-exposed RMECs. Cytosolic DHE exhibits
blue fluorescence; however, once this probe is oxidized by
O2
- to 2-hyroethidium (2-HE) and ethidium it fluoresces red
[27]. 2-HE is a specific O2
--derived product and is completely
inhibited by PEG-SOD. RMECs were plated onto FN-coated
and AGE-FN-coated coverslips in six-well dishes (Nunc) and
cultured for 24 h in 20% growth medium. After 24 h, the
medium was gently aspirated, washed thrice with PBS and
replaced  with  growth  medium  containing  2%  serum  for
further  24  h  incubation.  For  DHE  staining,  cells  were
incubated for 30 min in either Krebs-HEPES buffer, which
contained  99  mM  NaCl,  4.7  mM  KCl,  1.2  mM  MgSO4,
1.0 mM KH2PO4, 1.9 mM CaCl2, 25 mM NaHCO3, 11.1 mM
glucose, and 20 mM HEPES pH 7.3, or 100 units/ml PEG-
SOD that was reconstituted in Krebs-HEPES buffer. After this
initial incubation, the relevant buffer was aspirated from the
cells and quickly replaced with 100 µl Krebs-HEPES buffer
(unstimulated) or stimulated with 100 µl 10 mM NADPH
reconstituted in Krebs-HEPES. Immediately after addition of
NADPH, cells were incubated in 20 µM DHE for 10 min and
subsequently  subjected  to  confocal  scanning  laser
microscopy. The settings remained constant throughout the
course  of  the  assay.  When  microscopy  was  completed,
fluorescence intensity for each sample was analyzed using
Lucia  G/F  (Version  47)  image  analysis  software  (Nikon,
Kingston upon Thames UK Ltd).absorbance at 260/280 nm. cDNA was prepared from 1 μg
equivalent of the total RNA using the Sensiscript Reverse
Transcription (RT) kit (Qiagen) as per the manufacturer’s
instructions.
designed  using  Informax’s  sequence  analysis  and  primer
design  software,  Vector  NTI  (Invitrogen™  Life
Technologies)  from  bovine  DNA  and  RNA  sequences
obtained  from  The  National  Center  for  Biotechnology
Information (NCBI, Bethesda, MD; Table 1).
Quantitative  RT–PCR  was  performed  using  a
LightCycler rapid thermal cycler system (Roche Diagnostics
Ltd, Lewes, UK). Reactions were performed in a 10 μl volume
containing 1 μl cDNA template, 0.5 μM sense and anti-sense
primers,  deoxyribonucleotide  triphosphates  (dNTPs),  Taq
DNA  polymerase,  buffer  and  SYBR  Green  master  mix
(Qiagen). A typical protocol included an initial denaturation
step at 95 °C for 15 min followed by amplification of the
template for 36 cycles with 95 °C denaturation for 15 s, 53 °C
annealing for 15 s, and 72 °C extension for 10 s. The annealing
temperature  was  optimized  for  each  primer  set,  and  the
extension  period  depended  on  the  length  of  the  expected
product (approximately 5 s/100 base pairs, minimum 10 s).
Labeled product was detected at the end of the 72 °C extension
period. To confirm amplification specificity, we subjected the
PCR products from each primer to a melting curve analysis
and for new primer pairs, subsequent electrophoresis on a 2%
agarose gel. A Lightcycler quantification report was used to
obtain average crossover values. Data was expressed in terms
of  ΔΔct  (relative  gene  expression  crossover  value  in
comparison to housekeeping mRNA) values in comparison to
the control group.
Statistical analysis: Data were expressed as the mean values
±standard error of the mean (SEM). Statistical differences in
the mean were assessed using one-way ANOVA followed by
the  Tukey-Kramer  post-hoc  test  for  multiple  comparisons
unless  stated  specifically.  All  statistical  analyses  were
performed using SPSS 14.0, (SPSS, Chicago, IL) or GraphPad
InStat 3.0, (GraphPad Software, San Diego, CA). Data was
considered significant at 95% (p<0.05).
RESULTS
RMEC attachment and spreading: RMECs seeded onto AGE-
FN, which had been increasingly modified with 10, 50, and
100 µM MGO, for 3 and 6 h showed a significant step-wise
reduction in attachment capacity in comparison to cells grown
on native FN (p<0.001; data not shown). Using this data as a
foundation,  RMECs  were  again  seeded  onto  AGE-FN
(modified with 100 µM MGO) that had been treated with
RGDS peptides or control SDGRG peptides (Figure 1) to
determine if replacing the RGD motif could replenish AGE-
derived loss of attachment signals. The cells demonstrated a
significant  reduction  in  attachment  capacity  on  AGE-FN
when  compared  to  cells  cultured  on  native  FN,  while
supplementation  with  3  mM  and  6  mM  RGDS  peptide
significantly enhanced cell attachment (p<0.01–0.001; Figure
1). The scrambled peptide had no notable effect (Figure 1). A
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cDNA polymerase chain reaction (PCR) primers were
Figure  1.  RGDS  peptide  modulates
AGE-induced  RMEC  dysfunction.  A:
Phase-contrast  micrographs
demonstrate that AGE-FN reduces cell
attachment  and  spreading  when
compared  to  native  FN  controls.
RMECs cultured on AGE-FN that had
been  pretreated  with  1–6  mM  RGD
peptide showed an enhanced attachment
that  was  not  evident  from  control
(scrambled) peptide. Quantification of
the  RMEC  responses  revealed  a
significantly  reduced  attachment  on
AGE-FN  when  compared  to  cells
cultured  on  native  fibronectin  (B).
Supplementing  AGE-FN  with  RGDS
peptide (3 mM and 6 mM) significantly
rectified  cell  attachment  while
scrambled  peptide  had  no  significant
effect. A similar response was observed
for  RMEC  spreading  (C;  n=3;
**p<0.01; ***p<0.001).similar response was observed for RMEC spreading responses
(Figure 1).
Since  integrins  are  central  to  endothelial  cell  matrix
interactions, downstream signaling responses were evaluated.
RMEC signaling subsequent to attachment on FN and AGE-
FN substrates were evaluated by western analysis. The levels
of phospho-FAK (tyrosine397) were reduced when RMECs
were  grown  on  AGE-FN  when  compared  to  FN  control
(Figure 2A). This was especially evident at 45 min and 60 min
(Figure 2A).
FAK signaling requires clustering of integrins on the
plasma  membrane.  Investigation  of  integrin  α5β1
immunoreactivity showed that RMECs on FN had a relatively
uniform  immunofluorescence  immediately  adjacent  to  the
basal surface (Figure 2B). By contrast, RMECs on AGE-FN
exhibited a more intense immunofluorescence for α5β1 at the
basal plasma membrane and also in perinuclear organelles
(compare Figure 2B,C)
RMEC  mitochondrial  function  and  caspase-3  activity:
Appropriate  integrin-substrate  interactions  are  known  to
evoke  pro-survival  pathways,  therefore  mitochondrial
permeability, as an early indicator of apoptosis, was assessed.
Inner mitochondrial membrane potential was evaluated by
flow  cytometry  using  JC-1,  which  exhibits  dual  emission
properties depending on mitochondrial membrane potential.
As an entire population, cells grown on FN showed little
mitochondrial  permeability,  as  indicated  by  a  constitutive
red:green fluorescence intensity ratio that was significantly
shifted by exposure to AGE-FN (p<0.05; Figure 3). It was
apparent  that  AGE-exposed  cells  showed  a  degree  of
heterogeneity suggesting that, at this time point, some cells
were more prone to mitochondrial changes than others (Figure
3).
Caspase-3  activity  in  RMECs  was  analyzed  by
spectrofluorometry. This approach demonstrated that cells
exposed to AGE-FN had significantly increased activity of
this pro-apoptotic enzyme. Scrambled peptide plated onto the
AGE-modified substrate had no influence, but RGDS peptide
significantly, albeit incompletely, reduced caspase-3 activity
in RMECs growing on AGE-FN (*p<0.05; Figure 4).
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Figure  2.  AGE-modification  of  FN
alters  integrin-mediated  signaling  in
RMECs.  A:  western  blotting  analysis
showed that phospho-FAK (tyrosine397)
was reduced when RMECs were grown
on  AGE-FN.  Quantification  revealed
this  clear  differential,  which  is
especially evident at the 45 and 60 min
time point. B-G: Confocal microscopy
disclosed  integrin  α5β1
immunoreactivity in RMECs grown on
FN  and  AGE-FN.  B-D:  RMECs
cultured  on  native  FN  exhibited  a
relatively uniform distribution of α5β1
throughout the basal aspect of the cell
immediately adjacent to the substrate.
Deeper  (basal)  z-sections  showed
relatively weak fluorescence intensity at
the basal plasma membrane (basal PM;
D). E-G: RMECs cultured on AGE-FN
exhibited  a  greater  intensity  of  green
fluorescence indicative of higher α5β1
expression. Some RMECs exposed to
AGE-FN showed perinuclear punctuate
staining (F). Deeper z-sections showed
high  fluorescence  intensity  and  a
filamentous distribution at the basal PM
(G). All cells were counterstained with
propidium iodide.Figure 4. Activated caspase-3 induced by AGE-exposure is reversed
by RGD peptide. RMECs growing on AGE-FN show a significant
increase in caspase-3 activity. Scrambled peptide (SDGRG) plated
onto the AGE-modified substrate had no influence on caspase-3
activity, while exogenous RGDS significantly reduced caspase-3
activity  in  RMECs  cultured  on  AGE-FN,  although  this  is  an
incomplete reduction (n=3; *p<0.05).
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Superoxide  production  and  mRNA  expression  changes  in
RMECs: O2
- generation is not only linked to many AGE-
mediated cell responses [28] but is also central to endothelial
cell apoptosis [29]. Following on from the attachment studies
it was observed that a subset of RMEC remained attached and
spread  onto  the  AGE-modified  substrate.  This  “surviving
population”  of  RMECs  was  investigated  for  in  situ  O2
-
production using the lucigenin-enhanced chemiluminescence
assay. AGE-exposed cells demonstrated a significant increase
in O2
- when compared to controls (p<0.01; Figure 5A,B).
RMECs  from  both  substrate  groups  were  stimulated  with
NADPH. This resulted in marked O2
- production, although the
AGE-exposed cells showed significantly more than RMECs
growing on native FN (Figure 5C,D; **p<0.01).
As a complement to the lucigenin approach for measuring
O2
- production, an assay based on DHE fluorescence was used.
RMECs  again  showed  an  AGE-mediated  increase  in  O2
-
(Figure 6). RMECs growing on native FN demonstrated basal
levels of O2
-, but this was significantly increased when the
cells were treated with NADPH (p<0.001). O2
- was attenuated
with  co-incubation  with  PEG-SOD  (p<0.001;  Figure  6).
RMECs growing on AGE-FN produced greater levels of O2
-
Figure 3. RMECs growing on AGE-FN
show  enhanced  JC-1  mitochondrial
permeability  A-D:  Cells  grown  on
native FN (A) were gated to exclude cell
debris in a forward scatter versus side-
scatter  dot  plot.  This  dot  plot  is
expressed in terms of both the red and
green fluorescence intensity after JC-1
incubation (B). The histogram charts the
green (C) and red (D). E-H: The same
gating schemes were used for RMECs
growing on AGE-FN. Typical traces are
shown from RMECs on AGE-FN (100
µM MGO) and demonstrate that AGE-
exposed  cells  showed  shrinkage,
indicating apoptosis (compare A with
E). There is also a relative increase in
mitochondrial  permeability  in  AGE-
exposed  cells  as  indicated  by  the  net
decrease in the red:green fluorescence
intensity ratio (E-H). I: Quantification
of  JC-1  fluorescence  revealed  that
RMECs cultured on AGE-FN (modified
by  10–100  µM  MGO)  showed  a
significant  increase  in  mitochondrial
permeability  (red:green  fluorescence
intensity ratio) in comparison to cells
grown  on  native  FN.  (n=3;  *p<0.05;
comparison  between  AGE-FN  and
native FN).DISCUSSION
Cell  adhesion  and  survival  is  maintained  via  appropriate
interaction of cell integrin and nonintegrin receptors with BM
component proteins [4]. In this investigation, an in vitro model
of AGE-modification of FN was used to study the effect of
BM-immobilized adducts on retinal capillary endothelial cell
function. FN was chosen because it is a major BM constituent
protein and is known to accumulate AGE-modifications [31].
Furthermore,  MGO  is  an  established  precursor  for  AGE
formation with in vivo relevance and leads to modification of
arginine residues in many proteins of the diabetic retina [22].
Indeed,  it  has  been  estimated  that  MGO-derived
hydroimidazolone species could contribute up to 92% of total
arginine modification by MGO [32]. Importantly, MGO is
elevated  in  diabetic  serum  [33]  and  is  involved  in  AGE
formation in diabetic retinal capillaries [34].
The current investigation has uncovered a relationship
between AGE-FN, attachment and spreading and anoikis-
induced apoptosis in retinal capillary endothelium. Survival
after  attachment  to  a  substrate  requires  not  only  integrin
engagement, but subsequent cell spreading [35]. Failure to
spread  results  in  apoptosis  by  anoikis,  which  may  be
associated with retinal microvascular attenuation in human
and  experimental  diabetes  [36,37].  This  study  has
Figure  5.  AGE-FN  induce  O2-
production  in  RMEC.  The  lucigenin-
enhanced  chemiluminescence  assay
was used to determine O2- in RMECs. A
typical  trace  is  shown  for  RMECs
growing on native FN or AGE-FN (A).
Quantification  revealed  a  significant
increase in O2- when cells were growing
on AGE-FN (B). Cells stimulated with
NADPH  showed  a  significantly
enhanced O2- production (C) with the
RMECs  growing  on  AGE-FN,
producing  significantly  more  radicals
compared  to  controls  (D;  n=3;
**p<0.01).
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when  compared  to  FN  controls,  and  this  response  was
significantly enhanced by NADPH exposure (p<0.01). As
observed with RMECs growing on FN, PEG-SOD treatment
significantly  reduced  NADPH-mediated  O2
-  production
(p<0.01; Figure 6).
Previous studies have shown that AGE-modification of
the BM can increase expression of the component proteins at
both the protein and mRNA level, and this may contribute
significantly to the BM thickening lesion [30]. In the current
in vitro system it was anticipated that endothelial cells respond
to an inadequate substrate by increasing synthesis of matrix
proteins and enzymes that re-model the BM. Using this as a
rationale, we assessed mRNA expression of the BM protein
collagen  IV,  matrix  metalloproteinases  (MMP),  and  their
regulators. Quantitative RT–PCR demonstrated that RMEC
exposure to AGE-FN induced significant mRNA upregulation
of collagen IV when compared to cells growing on native-FN
(p<0.05;  Figure  7).  The  proteases  MMP-1,  MMP-2,  and
MMP-14 and also the protease inhibitors tissue inhibitor of
metalloproteinases-1  (TIMP-1)  and  TIMP-2  were  also
upregulated in RMECs growing on AGE-FN when compared
to native FN (p<0.05; Figure 7).demonstrated that AGE modification of the substrate perturbs
survival-related signal transduction particularly the integrin-
mediated  FAK/Akt  signal  transduction  pathway.  Impaired
FAK  phosphorylation  is  consistent  with  a  reduced
bioavailability  of  the  FN-derived  RGD  recognition  motif.
Data  from  the  cell  attachment,  spreading,  and  apoptosis
experiments show that there is a surviving subpopulation of
RMEC after 6 h culture on AGE-FN. These cells appear to
exhibit greater expression of the endothelial cell FN receptor
integrin  α5β1.  Increasing  both  expression  of  α5β1  and
concentrating  receptor  localization  may  increase  integrin-
mediated cell survival signaling through the FAK pathway
and  give  the  cells  more  opportunity  for  attachment  on  a
diabetes-related substrate.
The RGD motif is important for cell recognition and pro-
survival signaling [17,38]. Furthermore, the arginine residue
of RGD is highly susceptible to MGO-derived AGE adduct
formation.  These  modifications  reduce  adhesion  and
spreading activity of adherent cells [17,21]. Supplementation
of  AGE-modified  BM  with  exogenous  RGD-containing
peptides was undertaken to effectively replace AGE-linked
“depletion” of the RGD cell-recognition motifs on AGE-FN.
This supplementation enhanced the attachment and spreading
activation. This outcome confirms both the importance of the
RGD  motif  in  integrin-mediated  cell  survival  and  the
pathogenic  consequences  of  AGE  modification  of  BM
proteins. It should be noted that supplemented RGD peptides
were  not  completely  effective  at  reducing  apoptosis,
indicating that AGE substrates are likely to have a complex
influence on cell responses and survivability. There are a
range of integrin combinations, which are also likely to be
important  in  the  context  of  AGE-modifications  of  BM.
Integrins such as α1 β1 and α1 β2 bind to collagen IV [39],
and these interactions could also be significantly altered by
exposure to AGE-modified collagen IV [17].
In the current investigation, it has been observed that a
surviving subpopulation of cells remains attached and spread
on the AGE-modified substrate. This is significant because
although these cells remain viable it is possible that they
continue to experience an AGE-mediated “insult” from the
underlying substrate. It was considered that these cells could
be experiencing an oxidative insult, and we evaluated the
generation  of  O2
-  by  AGE-modified  substrate.  NADPH
oxidase and NADPH oxidase-derived O2
- plays an important
role in cell responses such as migration, proliferation, matrix
Figure  6.  AGE-FN  substrate  induces
O2- in RMECs. In situ O2- production, as
measured  by  DHE  florescence,  was
relatively  low  when  RMECs  were
grown on FN, but this increased when
the  cells  were  exposed  to  NADPH.
Treatment of RMECs with PEG-SOD
decreased fluorescence in RMEC below
basal  levels,  and  this  antioxidant
treatment  also  significantly  reduced
NADPH-induced O2-. RMECs growing
on AGE-FN showed higher basal levels
of  O2-  when  compared  to  native  FN
control  treatments,  and  this  response
was  further  increased  by  NADPH
exposure. As with RMECs growing on
FN, PEG-SOD can significantly prevent
O2- production (n=3; ***p<0.001).
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Figure 7. AGE-FN induces upregulation
basement  membrane  components  and
associated  enzymes.  Endothelial  cells
may respond to a modified substrate by
increasing synthesis of matrix proteins
and  enzymes  that  remodel  the  BM.
Real-time RT–PCR was used to assess
this  response.  RMECs  cultured  on
AGE-FN  displayed  significant
increases  in  BM-associated  mRNA
expression  in  comparison  to  RMECs
cultured on Native-FN (n=3).
metalloproteinase  activation,  and  extracellular  matrix
synthesis [40,41]. At high concentrations, this free radical can
overwhelm antioxidant defenses and lead to oxidative stress.
In  the  diabetic  state,  increased  glucose  metabolism  is
associated with an increase in cellular O2
- and associated cell
signaling events, although the effect of exposure to AGE-
modified substrate on O2
- production has not been previously
evaluated. The finding that AGE-modified substrate is linked
to enhanced O2
- is a novel and important finding, suggesting
that long-term modification of vascular BM during diabetes
could contribute to oxidative stress in retinal capillaries.
The ability to quench fluorescence via the addition of
PEG-SOD confirmed the major ROS as O2
-. The NADPH
stimulation outcomes indicate that the source of this radical is
vascular NADPH oxidase. The actual mechanism for an AGE-
linked O2
- increase is unknown but may directly involve AGE
stimulation of endothelial NADPH oxidase and subsequent
ROS production. Indeed, the binding of AGEs to the receptor
for  AGEs  (RAGE)  can  initiate  NADPH  activation  and
subsequent  production  of  O2
-  [42],  although  it  remains
unknown if substrate-immobilized AGEs can activate RAGE
in endothelial cells. This is an important issue that is beyond
the  scope  of  this  manuscript  but  is  currently  under
investigation.
In addition to demonstrating that RMECs cultured on
AGE-FN increase O2
- production, the current study has also
shown altered mRNA expression responses, particularly by
enzymes that modify the BM. Several studies have shown that
synthesis  of  BM  components  such  as  FN,  laminin,  and
collagen IV are upregulated by high glucose or diabetes; this
may be associated with the development of BM thickening
[30,43,44].  Although  expression  of  BM  constituents  is  a
pathological  hallmark  of  diabetes  and  considered  to  be
dysfunctional, it is possible that by secreting extracellular
matrix, these cells are actually attempting to increase integrin-
mediated  cell  survival  via  the  increased  production  of
integrin-specific  cell-surface  ligands.  AGE-modified
substrate is also associated with significant changes to mRNA
expression for MMP-1, MMP-2, and MMP-14 and TIMP-1
and  TIMP-2.  Previous  studies  indicate  that  the  ability  of
MMPs to modify AGE-modified matrices is compromised
[45], and this could further exacerbate the consequences of
diabetes-related BM modification.It  can  be  concluded  that  AGE-modification  of  BM
component  proteins  significantly  has  an  impact  on  the
function and, ultimately, survival of the retinal microvascular
endothelium. The ability of endothelium growing on such
modified  substrates  to  respond  to  the  progressive  insults
incumbent in the diabetic milieu is compromised. In turn, this
would impair reparative ability of the capillary endothelial
monolayer. AGEs are a heterogenous group of adducts, but
these findings indicate that arginine-specific modifications
within extracellular proteins by MGO could play an important
role in the pathogenesis of diabetic retinopathy.
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